World PulseNow
Newsletter

Trump is threatening U.S. pharma with tariffs of 100% to push them to bring manufacturing home, but it may not be so easy to dislodge companies from places like the Irish village of Ringaskiddy

Dow Jones – Health•Sunday, September 28, 2025 at 3:00:00 AM
NegativeHealth
Trump is threatening U.S. pharma with tariffs of 100% to push them to bring manufacturing home, but it may not be so easy to dislodge companies from places like the Irish village of Ringaskiddy
President Trump is taking a hard stance against U.S. pharmaceutical companies by threatening to impose 100% tariffs on those that do not manufacture their products in America. This move aims to encourage companies to bring their operations back home, but experts warn that it may not be as straightforward as it seems, especially for firms established in places like Ringaskiddy, Ireland. The implications of such tariffs could disrupt the pharmaceutical supply chain and impact drug prices, making this a significant issue for both the industry and consumers.
— Curated by the World Pulse Now AI Editorial System
Read Original

Was this article worth reading? Share it

Recommended Readings
President Trump’s skepticism over vaccines and warnings over the safety of Tylenol is calculated to appeal to his supporters
Dow Jones – Health18 hours ago
President Trump’s skepticism over vaccines and warnings over the safety of Tylenol is calculated to appeal to his supporters
NegativeHealth
President Trump's recent skepticism regarding vaccines and his warnings about the safety of Tylenol seem strategically aimed at resonating with his supporter base. This approach raises concerns about public health messaging and the potential impact on vaccination rates and medication safety perceptions, which are crucial in the ongoing fight against misinformation.
Read full article
via Dow Jones – Health
Heard on the Street: It’s becoming increasingly clear that pharmaceutical companies can live with Trump’s tariffs. What the industry can’t live with is uncertainty on drug prices
Dow Jones – Healtha day ago
Heard on the Street: It’s becoming increasingly clear that pharmaceutical companies can live with Trump’s tariffs. What the industry can’t live with is uncertainty on drug prices
NeutralHealth
The latest insights reveal that pharmaceutical companies are adapting to Trump's tariffs, but the real concern for investors lies in the uncertainty surrounding drug pricing. This lack of clarity can significantly impact the industry and investor confidence, making it a critical issue to watch.
Read full article
via Dow Jones – Health
Trump’s Pharma Tariffs Spare Richest Drugmakers
The New York Timesa day ago
Trump’s Pharma Tariffs Spare Richest Drugmakers
NeutralHealth
President Trump's proposed tariffs on pharmaceuticals have raised questions about which companies will be affected. While the specifics remain unclear, it appears that many of the largest drugmakers may receive exemptions. Notably, Merck has begun construction on a new factory in Delaware, which could position the company to benefit from a partial exemption. This situation highlights the ongoing complexities in the pharmaceutical industry and the potential implications for drug pricing and availability.
Read full article
via The New York Times
Despite False Claims, Trump Funnels Millions Into Credible Autism Research
The New York Timesa day ago
Despite False Claims, Trump Funnels Millions Into Credible Autism Research
PositiveHealth
In a significant move, the Trump administration has allocated $50 million in funding from the National Institutes of Health to support 13 research projects focused on understanding autism. This decision has been welcomed by scientists who are eager to explore complex theories beyond the common fears surrounding vaccines. This funding not only highlights a commitment to credible research but also aims to deepen our understanding of autism, which is crucial for developing effective interventions and support for affected individuals and their families.
Read full article
via The New York Times
How Trump’s Latest Tariffs May Affect Your Medicines
The New York Times2 days ago
How Trump’s Latest Tariffs May Affect Your Medicines
NegativeHealth
President Trump's announcement of a 100 percent tariff on certain brand-name drugs has raised concerns about the potential impact on healthcare costs and access to essential medicines. This move could significantly increase prices for consumers and strain the healthcare system, making it harder for people to afford necessary treatments. Understanding the implications of these tariffs is crucial as they could affect millions of Americans relying on these medications.
Read full article
via The New York Times
President Trump’s plan for pharmaceutical tariffs has many of the world’s richest drugmakers saying they expect to be unscathed by the levies
Dow Jones – Health2 days ago
President Trump’s plan for pharmaceutical tariffs has many of the world’s richest drugmakers saying they expect to be unscathed by the levies
NeutralHealth
President Trump's proposed pharmaceutical tariffs have prompted many of the world's wealthiest drugmakers to express confidence that they will remain unaffected by these levies. In anticipation of potential tariffs, these companies are proactively committing to invest billions in domestic manufacturing. This move is significant as it highlights the ongoing tension between government policies and the pharmaceutical industry, while also emphasizing the industry's efforts to adapt and maintain stability in a changing economic landscape.
Read full article
via Dow Jones – Health
AstraZeneca to Offer Discounted Drugs as Trump Pressures Pharma Industry to Cut Prices
Dow Jones – Health2 days ago
AstraZeneca to Offer Discounted Drugs as Trump Pressures Pharma Industry to Cut Prices
PositiveHealth
AstraZeneca has announced it will provide significant discounts of up to 70% on its asthma and diabetes medications in the U.S. This move comes as the Trump administration pushes for pharmaceutical companies to lower drug prices, making essential medications more accessible to patients. This initiative not only reflects AstraZeneca's commitment to public health but also responds to growing concerns about the affordability of healthcare in America.
Read full article
via Dow Jones – Health
Trump says research links Tylenol and autism; scientists say their paper is being misinterpreted
Los Angeles Times2 days ago
Trump says research links Tylenol and autism; scientists say their paper is being misinterpreted
NeutralHealth
Former President Trump has claimed that research connects Tylenol use during pregnancy to autism, but scientists are pushing back, stating that his interpretation of the study is incorrect. This discussion is significant as it touches on the safety of pain relievers for pregnant women, with doctors affirming that Tylenol remains the safest option available. Understanding the facts behind such claims is crucial for expectant mothers making informed health choices.
Read full article
via Los Angeles Times
Pharma Stocks Vary Worldwide Following New Trump Tariffs
Dow Jones – Health2 days ago
Pharma Stocks Vary Worldwide Following New Trump Tariffs
NegativeHealth
Pharma stocks are experiencing a mixed reaction globally following the announcement of new tariffs by Trump. While big pharmaceutical companies in the U.S. saw a slight uptick in premarket trading, smaller and midsize firms in Europe faced declines, and Asian pharma stocks fell significantly. This situation is important as it reflects the broader impact of trade policies on the pharmaceutical industry, which could affect drug prices and availability.
Read full article
via Dow Jones – Health
'Long history of blaming mothers': Trump's Tylenol warning echoes past misconceptions
NPR2 days ago
'Long history of blaming mothers': Trump's Tylenol warning echoes past misconceptions
NegativeHealth
Recent comments by Trump regarding Tylenol have reignited discussions about the historical tendency to blame mothers for autism. Medical experts emphasize that this approach not only misrepresents the complexities of autism but also perpetuates harmful stigma against parents. Understanding autism requires a nuanced perspective, and it's crucial to move away from outdated narratives that unfairly target families.
Read full article
via NPR
Trump May Try to Force Drugmakers to Match European Prices
The New York Times2 days ago
Trump May Try to Force Drugmakers to Match European Prices
NeutralHealth
President Trump is hinting at potentially more aggressive pricing policies for drugmakers, as indicated by a federal website notice that was briefly deleted and then reposted. This move could lead to drug prices in the U.S. aligning more closely with those in Europe, which may benefit consumers by making medications more affordable. It's a significant development in the ongoing conversation about healthcare costs and access.
Read full article
via The New York Times
Trump advises parents on hepatitis B vaccine. Here's why doctors say he's wrong
NPR3 days ago
Trump advises parents on hepatitis B vaccine. Here's why doctors say he's wrong
NegativeHealth
This week, President Trump stirred controversy by advising parents to postpone the hepatitis B vaccine for their children until they reach 12 years old. Medical professionals have strongly criticized this recommendation, labeling it as dangerous and misleading. Vaccination is a crucial public health measure, and such statements from a former president can significantly influence parental decisions, potentially putting children's health at risk.
Read full article
via NPR
Latest from Health
Trump is threatening U.S. pharma with tariffs of 100% to push them to bring manufacturing home, but it may not be so easy to dislodge companies from places like the Irish village of Ringaskiddy
Dow Jones – Health6 hours ago
Trump is threatening U.S. pharma with tariffs of 100% to push them to bring manufacturing home, but it may not be so easy to dislodge companies from places like the Irish village of Ringaskiddy
NegativeHealth
President Trump is taking a hard stance against U.S. pharmaceutical companies by threatening to impose 100% tariffs on those that do not manufacture their products in America. This move aims to encourage companies to bring their operations back home, but experts warn that it may not be as straightforward as it seems, especially for firms established in places like Ringaskiddy, Ireland. The implications of such tariffs could disrupt the pharmaceutical supply chain and impact drug prices, making this a significant issue for both the industry and consumers.
Read full article
via Dow Jones – Health
Florence Welch says she had life-saving surgery after ectopic pregnancy
BBC News6 hours ago
Florence Welch says she had life-saving surgery after ectopic pregnancy
PositiveHealth
Florence Welch recently revealed that she underwent life-saving surgery following an ectopic pregnancy, shortly after her performance at a festival in August 2023. This news is significant as it highlights the importance of women's health and the potential risks associated with pregnancy complications. Welch's experience serves as a reminder of the need for awareness and timely medical intervention.
Read full article
via BBC News
Responding to a WSJ article about pulmonary embolism, readers built a rich library of insights about dealing with medical emergencies
Dow Jones – Health10 hours ago
Responding to a WSJ article about pulmonary embolism, readers built a rich library of insights about dealing with medical emergencies
PositiveHealth
After a Wall Street Journal editor shared her experience with a pulmonary embolism, a community of survivors came together to share valuable insights on handling medical emergencies. This exchange not only highlights the importance of awareness around such health issues but also fosters a supportive network for those affected, showing how shared experiences can empower individuals in times of crisis.
Read full article
via Dow Jones – Health
Doctors Without Borders Closes in Gaza City as Israel Intensifies Offensive
The New York Times15 hours ago
Doctors Without Borders Closes in Gaza City as Israel Intensifies Offensive
NegativeHealth
Doctors Without Borders has withdrawn its staff from Gaza City as the region's medical system collapses under the strain of ongoing conflict. This decision highlights the dire humanitarian situation, with the U.N. warning that more hospitals may soon close. The emotional toll is evident as Palestinians gather to bury their loved ones outside Al-Shifa Hospital, unable to reach cemeteries due to the Israeli ground invasion. This situation underscores the urgent need for international attention and support for those affected.
Read full article
via The New York Times
A chance to end the global HIV epidemic: low-cost preventative drug to roll out on 2027
France 2416 hours ago
A chance to end the global HIV epidemic: low-cost preventative drug to roll out on 2027
PositiveHealth
Exciting news in the fight against HIV: starting in 2027, generic versions of lenacapavir, a groundbreaking injectable drug, will be available for just $40 a year in over 100 countries. This initiative, led by Unitaid and the Gates Foundation, aims to make HIV prevention accessible to low- and middle-income nations. With lenacapavir proven to reduce the risk of HIV transmission by more than 99.9%, this rollout could significantly impact global health and help end the HIV epidemic.
Read full article
via France 24
HIV-prevention drug to be available for $40 a year from 2027
France 2416 hours ago
HIV-prevention drug to be available for $40 a year from 2027
PositiveHealth
Starting in 2027, a groundbreaking HIV prevention drug, lenacapavir, will be available for just $40 a year in low and middle-income countries. This initiative, backed by deals with Indian manufacturers, aims to make this highly effective medication accessible to millions, potentially curbing the HIV epidemic significantly. Experts are optimistic that this move will not only improve health outcomes but also reduce the stigma associated with HIV, making a real difference in communities worldwide.
Read full article
via France 24